Posted: July 13th, 2018
Shionogi Sieyaku Kabushiki Kaisha, AstraZeneca UK Limited, AstraZeneca Farmacéutica Spain, S.A. v. Ratiopharm España, S.A., Court of Appeals of Barcelona, Section 15, 16 May 2018, Docket No. 59/2018 In a first instance judgment dated 12 July 2017, Commercial Court No. 5 of Barcelona concluded that use claims in the Swiss-type format, being purpose-related process claims, […]
READ MORE
Posted: July 11th, 2018
Barcelona Commercial Court No. 1, SCA TISSUE FRANCE SAS vs. INDUSTRIE CARTARIE TRONCHETTI IBÉRICA S.L., 26 March 2018, Docket No. 84/2018 On 26 March 2016, Barcelona Commercial Court No. 1 issued a first-instance decision declaring that the offering and manufacturing by ICT of several models of toilet paper products infringed SCA’s patent rights. The Court […]
READ MORE
Posted: July 3rd, 2018
Eli Lilly and Company, ICOS Corporation, and Eli Lilly Danmark A/S (“Eli Lilly”) v. Sandoz A/S (“Sandoz”), the Danish Maritime and Commercial High Court, Case number A-49-17, 15 June 2018 The case concerns infringement of Eli Lilly’s patent DK/EP 1 173 181 T6 (“DK/EP ‘181”) which relates to the use of the active substance Tadalafil […]
READ MORE
Posted: June 29th, 2018
Hungarian Constutional Court rules that UPCA cannot be ratified On 29th June, 2018 the decision of the Hungarian Constitutional Court was published on the Court’s website following the Hungarian Government’s motion for the interpretation of the Hungarian Constitution (Basic Act) in relation to the ratification of the UPC Agreement. Today the Constitutional Court ruled that […]
READ MORE
Posted: June 21st, 2018
Validity of Gilead’s Swiss TRUVADA® SPC confirmed but Switzerland will move away from the “infringement test” for future SPCs for combination products, By Simon Holzer, Kilian Schärli and Marco Borer, Meyerlustenberger Lachenal * English translation of the decision now included * The Swiss Federal Supreme Court issued a landmark decision concerning the requirements for Supplementary Protection Certificates […]
READ MORE
Posted: June 20th, 2018
High Point SARL v. KPN B.V., Court of Appeal The Hague, The Netherlands, 5 June 2018, Case no. ECLI:NL:GHDHA:2018:1271 High Point is the owner of EP 0 522 772 which relates to a ‘Wireless access telephone-to-telephone network interface architecture’. It has sued KPN for infringement. KPN, in turn, has claimed the invalidation of EP 772. […]
READ MORE
Posted: June 12th, 2018
Resolution Chemicals Ltd. v. AstraZeneca B.V. and Shionogi Seiyaka Kabushiki Kasiha, Supreme Court of The Netherlands, The Hague, 8 June 2018, Case No. ECLI:NL:HR:2018:854 This case relates to the scope of protection of a patent for a cholesterol inhibitor, more importantly whether or not the description of the patent provides for a limiting definition of […]
READ MORE
Posted: June 11th, 2018
Preliminary injunction issued by a French court against Teva’s generic of Novartis’ Exforge anti-hypertensive drug (valsartan/amlodipine) plus €13,000,000 awarded as an advance on damages On 7 June 2018, the tribunal de grande instance of Paris (Judge Marie Courboulay) issued a preliminary injunction against Teva’s generic of Novartis’ anti-hypertensive drug Exforge (valsartan/amlodipine) on the basis of […]
READ MORE
Posted: June 8th, 2018
Nikon Corporation v. ASML Holding N.V., ASML Netherlands B.V. and ASML Systems B.V., District Court of The Hague, 6 June 2018, Case no. ECLI:NL:RBDHA:2018:6542 This is case no. 2 of 11 patent cases between Nikon and ASML. The Court rules that ASML does not infringe the Dutch part of Nikon’s EP 2 157 480 relating […]
READ MORE
Posted: June 8th, 2018
Edwards Lifesciences LLC v. Boston Scientific Scimed Inc, High Court of Justice, London, UK, 24 May 2018, [2018] EWHC 1256 (Pat) In this judgment of 24 May 2018, the latest in a saga during which the Court of Appeal had upheld an infringement decision of the Patents Court, Arnold J determined the details of a […]
READ MORE
EMAIL US
